Search

everythinglearnresearchcommunity

for

Search:↓

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Erlotinib can cause hair loss as a side effect.

Hair is mostly made of three protein types: helical, high-sulfur, and high-tyrosine.

The drug combination was safe and showed promise in treating advanced tumors.

Mutations in β1 integrins cause embryonic death but have milder effects on skin.

Young female Australian fur seals are losing hair due to low tyrosine and zinc levels and high pollution exposure.

Naked-mouse hair lacks certain proteins and has less soluble fibril.

Finasteride affects young male rats' brain function and behavior negatively.

The N gene affects the protein makeup of mouse hair.

Brindled mice show abnormal catecholamine neuron development due to copper deficiency.

Nilotinib can cause skin issues like red bumps and hair loss.

A woman's hair turned white after taking a cancer drug called dasatinib.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

We know less about human hair pigmentation than mouse coat color, but pH and cysteine levels are key factors.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Rat skin has a linear system of nerve fibers linked to hair follicles and muscles.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Nilotinib can cause generalized keratosis pilaris.

Metabolic disorders can cause hair structure defects and growth issues, but amino acid levels in hair remain normal.

Gefitinib can cause hair and eyebrow darkening.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Brown skin in guinea pigs has more ascorbic acid and related enzymes, black skin uses ascorbic acid well, and white skin has the most protein.

Certain drugs can change hair color, either lightening or darkening it.

Gray hair can potentially be reversed, leading to new treatments.